The risk of developing food allergy in premature or low-birth-weight children

Joel J Liem1, Anita L Kozyrskyj, Shamima I Huq

  • 1Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada.

Insights

Premature or low-birth-weight children do not have an increased risk of developing food allergies. This study found no significant association between birth weight or gestational age and food allergy development.

Area of Science:

  • Pediatric Allergy and Immunology
  • Neonatology
  • Gastroenterology

Background:

  • Premature and low-birth-weight infants exhibit increased gut permeability compared to full-term infants.
  • This heightened intestinal permeability may suggest a potential vulnerability to allergic conditions.

Purpose of the Study:

  • To investigate the association between prematurity/low birth weight and the risk of developing food allergies in children.
  • To determine if infants born prematurely or with low birth weight are more susceptible to food allergies.

Main Methods:

  • Utilized the 1995 Manitoba Birth Cohort data from the Manitoba Health Services Insurance Plan (MHSIP) database.
  • Identified food allergy diagnoses (ICD-9-CM code 693 or epinephrine prescription) up to 2002.
  • Calculated relative risks comparing food allergy incidence in premature/low-birth-weight infants versus term/normal-birth-weight infants.

Main Results:

  • A cohort of 13,980 children born in 1995 was analyzed.
  • Food allergy was diagnosed in 4.23% of children, with epinephrine prescribed for 2.26%.
  • No statistically significant increased risk for food allergy was observed in any gestational age or birth weight group.

Conclusions:

  • Prematurity and low birth weight are not linked to an altered risk of developing childhood food allergies.
  • Gastrointestinal tract or immune system immaturity in premature infants does not appear to increase food allergy risk.
  • Further research is needed to explore potential protective mechanisms, such as early food antigen exposure promoting immune tolerance.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65